Evaluate pharmacovigilance software with real case-processing controls

Fast case entry is an incomplete demonstration

A supplier creates a case in minutes and generates a polished report. The demonstration looks efficient, but it does not show what happens when new information arrives, a source detail is corrected or an outbound transmission fails.

Pharmacovigilance software should be evaluated against the work the safety team must perform over the case lifecycle. The question is whether qualified staff can process, review, correct and reconcile information with an understandable record of their decisions.

The Indian Pharmacopoeia Commission (IPC) guidance for marketing authorisation holders (MAHs) provides Indian pharmacovigilance (PV) context, including processing, quality and reporting activities. Actual obligations depend on applicable rules, markets and approved procedures; software selection cannot be based on one generic reporting configuration. IPC pharmacovigilance guidance for MAHs.

Establish the intended scope before requesting proposals

List the products, markets, report sources and organisational responsibilities in scope. Identify whether the system will support intake, case processing, review, reporting, reconciliation or additional activities. Distinguish planned future capabilities from the functions required for the first release.

Map the relationship with service providers. A company may outsource processing while retaining oversight and other responsibilities. The platform needs to support the actual operating agreement, including access to evidence, issue management and continuity if the provider changes.

Write the intended use for each automated function. Extracting text, suggesting terminology and making a safety assessment are different activities with different consequences. Keep qualified medical and PV decisions in the authorised roles; do not let a feature name obscure who is accountable.

Model the case and its source records

Define the identities that must remain distinct: incoming communication, case, follow-up, source attachment, processing version and submission. A case can receive several communications and generate several reporting events. One identifier should not be stretched to mean all of them.

Ask the supplier to show how the current case information relates to its source evidence. When a field changes, reviewers should be able to understand what changed, why, who acted and which information supported the revision.

The case-intake guide explains receipt and handover evidence. Those records should survive entry into the safety database rather than being replaced by the database import timestamp.

Use a complete scenario for every supplier

Build a common demonstration script using synthetic data approved by the PV team. Include an initial communication, follow-up, potential duplicate, reviewer query, corrected information and a failed interface. Ask suppliers to show the proposed configuration and identify any manual steps.

Score what the system demonstrates, not what a sales presentation promises. Record whether each behaviour is standard, configurable, customised or dependent on another service.

Worked example: one case, several processing challenges

Consider an illustrative initial report received through customer service. The intake contains incomplete information and an attachment. Qualified PV staff assess it under the approved process and create the appropriate record, preserving its source and receipt history.

A follow-up arrives with a corrected event date. The system should retain the original reported information and show how the authorised reviewer incorporated the correction. A current-value screen alone is insufficient to explain the processing history.

Next, a distributor message appears to describe the same event. The system proposes a possible relationship, but a qualified reviewer assesses the evidence before any case-level linkage. Both communications remain traceable, including the information unique to each.

An outbound interface then fails after the application has prepared an approved reporting output. The dashboard should distinguish preparation, transmission attempt and confirmed outcome. A retry must not create an uncontrolled duplicate or reset the original source history.

The reviewer finally needs to reconstruct the case from the initial communication through the latest processing state. Ask the supplier to produce that view and the associated export. This single scenario exposes more useful buying evidence than a series of isolated feature demonstrations.

The example does not determine reportability, seriousness or a reporting deadline. The PV and regulatory owners configure and apply the relevant requirements for the actual case context.

Evaluate follow-up and duplicate handling

Follow-up should add evidence without obscuring what was known earlier. Review how the system tracks requests, responses, missing information and unresolved questions. A completed contact attempt should not automatically mean the information gap has been resolved.

The duplicate-reconciliation guide describes the distinction between technical replay and case-level similarity. Ask suppliers to demonstrate an uncertain match, an authorised linkage and correction of an incorrect linkage.

Inspect the consequences for downstream work. A linkage can affect review, reporting and partner reconciliation. The platform should expose those dependencies and retain an accountable resolution rather than treating a merge action as the end of the process.

Keep reporting configuration under regulatory ownership

Create a controlled register of reporting contexts, destinations, formats and timing rules. The responsible PV and regulatory functions should approve the applicability and configuration. A country selection in a dropdown is not evidence that every relevant obligation has been addressed.

Ask how the supplier updates regulatory content and how the organisation assesses those updates. Identify what can change automatically, what requires review and what verification evidence is available. The team should be able to reconstruct which configuration applied to a particular reporting event.

Test the status model carefully. A file generated, a message sent, a transport acknowledgement and a successful business acceptance can be different states. Define what each acknowledgement means for each interface and how rejection or uncertainty is resolved.

Inspect source fidelity and reviewer control

Where extraction or AI assistance is proposed, show the original evidence beside the suggested fields. Reviewers should be able to correct the suggestion without losing provenance. Missing information must not be invented to satisfy mandatory fields.

Evaluate difficult inputs such as ambiguous dates, multilingual source text, poor scans and conflicting follow-up. Measure errors relevant to the intended use, including omissions and unsupported additions. An average accuracy score can conceal a small category with consequential failures.

Define the approved fallback when automation is unavailable or unreliable. Qualified users need a workable route to continue the necessary process. The organisation should not depend on a model's confidence score to decide whether information reaches PV review.

Check permissions and outsourced operations

Map roles for intake, processing, medical assessment, quality review, reporting, administration and supplier support as applicable. Determine which combinations are permitted under the approved operating model and which actions require separate authority.

Test access through search, attachments, exports and support tools. A restricted case screen is insufficient if a broad report exposes the same information. Include service accounts and integration credentials in the assessment, with accountable ownership and a lifecycle process.

For outsourced teams, demonstrate onboarding, role change and termination. Historical actions should remain attributable after access ends. The sponsor or MAH should retain the evidence and oversight access required by its responsibilities and agreements.

Assess validation using the actual intended use

The system owner and quality function should define the applicable assurance approach. Review supplier development and testing evidence, configuration controls, interface behaviour and the organisation's responsibilities. A vendor's “validated” label does not establish that the proposed implementation is suitable for every intended use.

Use risk and consequence to focus verification on the decisions and records users rely on. Include date handling, status transitions, reporting rules, permission boundaries and exception recovery. Tests should establish meaningful behaviour rather than merely confirm that buttons can be clicked.

EU GMP Annex 11 may be relevant where the assessed use falls within its scope; it is not a universal PV-software certification. Apply the requirements appropriate to the system's actual regulatory context. EU GMP Annex 11.

Plan migration around meaning and relationships

Inventory the records that must move: cases, source documents, follow-up histories, coding information, relationships, processing states and reporting evidence as applicable. Define the approved mapping and the treatment of incomplete or inconsistent legacy data.

The data migration validation guide explains why matching counts are insufficient. A migration can preserve the number of cases while losing their source relationships or changing the meaning of a status.

Use representative difficult cases for verification, including corrected dates, linked reports, multiple follow-ups and failed submissions. Reconcile open work at cut-over so neither platform loses ownership of an outstanding action. Agree rollback or recovery conditions before the live transition.

Evaluate continuity and supplier exit

Ask how essential work continues during an outage and how records are reconciled after recovery. Test the approved continuity process with the operating team. A backup statement alone does not demonstrate that the organisation can retrieve and use its records when needed.

Review export capability before signing a long-term commitment. The export should preserve the information and relationships needed for the intended retention and transition purpose. Confirm format documentation, access to attachments, costs and assistance required from the supplier.

Assign an owner for periodic retrieval checks after implementation. Include a case with an older attachment format and a closed user account so the review establishes practical usability rather than merely confirming that archived files still occupy storage.

Consider dictionary, interface and configuration dependencies in the exit plan. A database file without the context needed to interpret its values may be expensive to migrate and difficult to review later.

Compare lifecycle cost and operating value

Estimate implementation, licences, interfaces, migration, validation, training, administration, regulatory configuration and ongoing support. Include internal reviewer and reconciliation effort. Automation can move work into exception handling rather than remove it.

Set a baseline using the team's actual case mix. Useful measures include time spent locating source evidence, unresolved interface outcomes, correction effort and review queries caused by incomplete intake. Compare like-for-like work and avoid presenting illustrative speed gains as proven client results.

Run a bounded pilot with explicit acceptance conditions and named decision owners. NextEdge Labs can help assess intake and integration workflows around the selected platform, while qualified PV and medical roles retain their defined authority.

Summary and next actions

The strongest PV software evaluation follows the case through uncertainty, correction and failure. A platform should preserve evidence and support qualified decisions throughout its operating life.

• Define intended scope, markets, roles and the source-to-reporting record model.
• Give suppliers one common scenario with follow-up, duplicate review, correction and failed delivery.
• Assess validation, migration, access, continuity and export using demonstrable evidence.
• Compare total operating cost and pilot outcomes before approving wider implementation.